Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation.
- 29 December 2014
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 36 (11), 653-656
- https://doi.org/10.1093/eurheartj/ehu494
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Patient’s values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulationThrombosis and Haemostasis, 2014
- Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmaciesThrombosis and Haemostasis, 2014
- Vitamin K antagonists in heart disease: Current status and perspectives (Section III)Thrombosis and Haemostasis, 2013
- Antithrombotic drug development for atrial fibrillation: Proceedings, Washington, DC, July 25-27, 2005American Heart Journal, 2008
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial FibrillationAnnals of Internal Medicine, 2007
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial FibrillationCirculation, 2006
- Anticoagulation Therapy for Stroke Prevention in Atrial FibrillationJama-Journal Of The American Medical Association, 2003
- Ethnic Differences in Patient Perceptions of Atrial Fibrillation and Anticoagulation TherapyStroke, 2002
- Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study Commentary: Varied preferences reflect the reality of clinical practiceBMJ, 2001
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyThe New England Journal of Medicine, 1989